Published by Summer Associates Tax Services, Stamford, Connecticut[email protected]
The Founder’s Tax LetterTax planning for Connecticut founders, early employees and startups

Call our Stamford office(203) 327-4311

Early equity planning can lower the tax you pay at exit.

QSBS, 83(b) elections, and R&D credits can lower the tax founders, early employees, and startups pay, and are easiest to get right early. Summer Associates models the federal and Connecticut tax on the exercise and sale scenarios you choose, before you act.

Request a free consultation or call (203) 327-4311

QSBS kept $3,705,900 of tax off a $12 million exit

Hypothetical case study: A $12 million exit gain excluded under QSBS. Read the case study

Startup office at night with a city skyline and a whiteboard of product diagrams

What these strategies can be worth

Each strategy below has a case study showing the tax before and after, using 2026 federal and Connecticut rules.

These examples are hypothetical. They apply 2026 federal and Connecticut rules to simplified facts, leave out professional fees, and include some benefits that defer tax rather than eliminate it.

Where founders can lower their tax, from formation to exit

Much of a founder's tax at exit is set at formation and the first equity grants.

Guides

Plain-English explainers covering the rules, the numbers, and the common mistakes.

The 2026 numbers that matter

The federal and Connecticut figures founders and early employees use when planning equity grants, option exercises, and an exit.

Item2026 figureNotes and source
QSBS gain exclusion cap$15M or 10x basisWhichever is greater, for stock issued after July 4, 2025 (Crowell)
QSBS gross assets limit$75MApplies to stock issued after July 4, 2025, versus $50M for earlier stock, and is tested before and immediately after issuance
QSBS holding periods3 / 4 / 5 years50% / 75% / 100% exclusion for new stock
83(b) election deadline30 daysFrom the date restricted stock is transferred, or issued, to you
R&D credit payroll offsetUp to $500,000For qualified small businesses (IRS Form 6765 instructions)
2026 AMT exemption, single / joint$90,100 / $140,200Phase-out begins at $500,000 / $1,000,000
Connecticut R&D credit exchange65% (90% biotech)Cash refund of a small company's unused current-year CT R&D credits, up to $1.5M a year (Source)
Connecticut angel investor credit25%Of a $25,000+ investment in an approved CT business. FY2027 credits are fully reserved, and the program reopens July 1, 2027 (Source)

Common questions

What changed with QSBS in 2025?

For stock issued after July 4, 2025, the per-issuer cap rose to the greater of $15 million or 10 times basis, the gross assets limit rose to $75 million, and partial exclusions of 50% at three years and 75% at four years were added, with 100% at five years. These are federal rules. California doesn't follow the QSBS exclusion, and several other states limit or deny it, so state tax may still apply.

What happens if I miss the 83(b) deadline?

The 30-day deadline is strict. If you miss it, each tranche of stock is taxed as ordinary income when it vests, based on the value then. Sometimes a company can cancel and reissue the grant, but that restarts the holding period.

Can a startup deduct R&D costs immediately again?

Yes. §174A, added in 2025, allows domestic research and experimental costs to be deducted currently starting in 2025. Small businesses could also elect to apply it retroactively to 2022–2024, though that election window closed by July 6, 2026.

Will exercising ISOs trigger AMT?

It can. The spread between the exercise price and fair market value is an AMT adjustment. For 2026, the AMT exemption is $90,100 single and $140,200 joint, phasing out at 50 cents per dollar above $500,000 and $1,000,000.

Does Connecticut tax QSBS gain?

Not if the gain is excluded federally. Connecticut income tax starts from federal adjusted gross income and has no add-back for gain excluded under Section 1202, so that gain is excluded for Connecticut too. Gain that isn't excluded, such as the 50% that remains taxable on a three-year sale, is taxed at Connecticut's regular rates of up to 6.99%.

Can a Connecticut startup get cash for unused R&D credits?

Yes. A C corporation with prior-year gross income of $70 million or less can exchange its current-year Connecticut R&D credits for a refund of 65% of their value, or 90% for small biotech companies, up to $1.5 million a year. To qualify, it must have no Connecticut corporation tax liability beyond the $250 minimum or, in a year with no net income, the capital base tax. It applies on Form CT-1120 XCH with a timely filed return. From 2026, partnerships and S corporations have a separate 6% R&D credit with the same 65% and 90% exchange.

Call (203) 327-4311Free consultation